Skip to content
Open access

Immune-related gene expression links anxiety, depression, and pain outcomes in adolescence

Oct 2026 · Communications Medicine · Vol 6 · 0 citations · 34 references
Medicine

Abstract

Chronic pain and internalising disorders such as anxiety and depression frequently co-occur during adolescence. Although prospective associations between internalising symptoms and later pain have been reported previously, the biological mechanisms underlying individual differences in this relationship remain poorly understood. Immune- and oxidative stress-related pathways, including the NRF2 gene, may contribute to such variability. This study investigated whether polymorphisms in the NRF2 gene (rs6721961 and rs35652124) are related to the association between anxiety and depression symptoms at age 14-15 and pain complaints two years later at age 16-17. Data were drawn from the IMAGEN longitudinal study (N = 724). Anxiety and depression symptoms were assessed using the Development and Well-Being Assessment (DAWBA), and pain complaints were measured via the Children’s Somatization Inventory (CSI). Genotyping was conducted for NRF2 SNPs rs6721961 and rs35652124. Regression analyses tested main effects, followed by genotype-stratified analyses. Consistent with previous literature, higher levels of anxiety and depression at age 14-15 predicted increased pain complaints at age 16-17. Carriers of the TG/TT genotype of rs6721961 had significantly lower anxiety scores and reported fewer pain complaints compared to those carrying the GG genotype of rs6721961. Notably, the association between anxiety and later pain was significant only among individuals with the GG genotype. While replicating established associations between adolescent early internalising symptoms and later pain, this study suggests that genetic variation in NRF2 is related to the anxiety-pain association. Specifically, rs6721961 is associated with differences in susceptibility to pain among adolescents with elevated anxiety symptoms. Anxiety and depression symptoms during adolescence are associated with greater pain complaints later in life, but the biological mechanisms underlying this relationship remain unclear. Emerging evidence suggests that NRF2, a protein that helps regulate the body’s response to inflammation and oxidative stress, may play an important role. Using data from a longitudinal study, in which symptoms of anxiety, depression and pain were assessed, we found that adolescents with higher levels of anxiety and depression at age 14 reported more pain complaints at age 16. We also found that a common genetic variation in the NRF2 gene (rs6721961) was associated with differences in vulnerability to pain among adolescents with elevated anxiety symptoms. These findings support further research into the role of NRF2-related genetic variation in pain vulnerability and may improve our understanding of early risk pathways in young people experiencing psychological symptoms. Le et al. use longitudinal data to examine whether polymorphisms in the NRF2 gene are associated with affective symptoms and pain. They find that higher levels of anxiety and depression at age 14 predicted increased pain complaints at age 16 and the NRF2 rs6721961 polymorphism is associated with differential vulnerability to pain.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.